Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07458568 · ClinicalTrials.gov registry record
ViBandz Feasibility Study
A clinical trial, sponsored by Children's Mercy Hospital Kansas City.
- Recruiting
- Registry status
- 30
- Enrollment target
NCT07458568: Recruiting study, sponsored by Children's Mercy Hospital Kansas City.
NCT07458568 is a clinical trial that is actively recruiting participants, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07458568 is actively recruiting participants, sponsored by Children's Mercy Hospital Kansas City.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
Study Summary
This is a single site, mixed methods, feasibility study of the ViBandz device at a Midwest pediatric tertiary care hospital in a physical and occupational therapy clinic.
Primary Outcome
Overall themes to be investigated will include ease of use, perceived comfort in using the ViBandz in the home setting, suggestions for changes/improvements to the ViBandz, and any additional comments. This will be gathered through the use of the System Usability Survey that will be administered via REDCap to parents following use of the ViBandz device for targeted vibration therapy.
Interventions
- DEVICE ViBandz
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-04-07 |
| Est. Completion | 2026-12-31 |
What NCT07458568 shows while recruiting
NCT07458568 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which ViBandz is the first listed.
NCT07458568 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07458568 about?
NCT07458568 is a clinical study titled "ViBandz Feasibility Study". This is a single site, mixed methods, feasibility study of the ViBandz device at a Midwest pediatric tertiary care hospital in a physical and occupational therapy clinic.
What is the current status of trial NCT07458568?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2026-04-07. Estimated completion is 2026-12-31.
What interventions are being tested in trial NCT07458568?
The interventions under investigation include: ViBandz (DEVICE).
Who is sponsoring clinical trial NCT07458568?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI